Left Atrium Auricle (LLA) closure

This presentation analyzes the feasibility of a program of percutaneous closure of the left atrium auricle (n = 54 p) in patients at high embolism risk and hospital based results – on 30 days. 

Solaci-euroPCR-AD-Damonte
A. Damonte
2012-05-15

More articles by this author

TAVI registry: Iberoamerica

The objective of this presentation (n = 1248 p, 43 centers in Europe and Latin America) is to evaluate immediate and long-term results of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...